Showing results (71-80 of 264) with videos related to

Sort By:
Pageof 27
Current Opinion in Molecular Therapeutics|June 28, 2005
Smoking cessation treatment: pharmacogenetic assessmentMarcus R Munafò, Caryn Lerman, Raymond Niaura, et al.
Drug and Alcohol Dependence|July 9, 2025
A multi-site study examining the tobacco withdrawal trajectory in people with tobacco and cannabis co-useRachel A Rabin, Caryn Lerman, Robert Schnoll, et al.
Neuropharmacology|June 20, 2003
Smoking, alcoholism and genetic polymorphisms alter CYP2B6 levels in human brainSharon Miksys, Caryn Lerman, Peter G Shields, et al.
JAMA Psychiatry|March 14, 2014
Large-scale brain network coupling predicts acute nicotine abstinence effects on craving and cognitive functionCaryn Lerman, Hong Gu, James Loughead, et al.
Pharmacogenomics|July 15, 2005
Pharmacogenetics and nicotine addiction treatmentMarcus R Munafò, Alexandra E Shields, Wade H Berrettini, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 17, 2009
Nicotinic acetylcholine receptor beta2 subunit (CHRNB2) gene and short-term ability to quit smoking in response to nicotine patchKenneth A Perkins, Caryn Lerman, Melissa Mercincavage, et al.
Biological Psychiatry|January 26, 2016
Brain Responses to Smoking Cues Differ Based on Nicotine Metabolism RateMary Falcone, Wen Cao, Leah Bernardo, et al.
Drug and Alcohol Dependence|August 26, 2006
New lower nicotine cigarettes can produce compensatory smoking and increased carbon monoxide exposureAndrew A Strasser, Caryn Lerman, Paul M Sanborn, et al.
Drug and Alcohol Dependence|June 4, 2013
Effects of bupropion on cognitive performance during initial tobacco abstinenceKenneth A Perkins, Joshua L Karelitz, Nancy C Jao, et al.
Behavioural Brain Research|July 5, 2008
Neuroimaging, genetics and the treatment of nicotine addictionRiju Ray, James Loughead, Ze Wang, et al.
Pageof 27